Abbott Laboratories is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Abbott Laboratories performs diagnostics and sells medical devices, medicines, and nutritional products such as Pedialyte. Its products and services help people treat and prevent diseases and chronic conditions. Its treatments help people experiencing pain, movement disorders, diabetes, heart conditions, and more.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Medical device research and development is responsible for substantive gains in length and quality of life, perhaps most profoundly in fighting cardiovascular disease and immobility via implantable technologies, and in expanding the scope of illnesses that can be detected in a more timely or less invasive fashion. Abbott Laboratories is responsible for positive Humankind Value, with much of its positive value coming from Medical Devices ($118.8 B) and Healthcare R&D ($44.0 B). Out of every company we have analyzed, Abbott Laboratories is in the top ten for Medical Devices. The value associated with Medical Devices and Healthcare R&D contains our estimation of 3,378,396.7 additional years lived by people worldwide. However, there is room for improvement with respect to Breastmilk Substitutes (-$98.3 B). Companies involved in the production and sale of breastmilk substitutes are attributed negative Humankind Value. While breastmilk substitutes are sometimes necessary, their usage has resulted in many childhood deaths due to increased transmission of early childhood infections through prepared formula. Medical Devices, Healthcare R&D, and Breastmilk Substitutes are attached to this company as a result of its direct business activities. While this company has a positive Humankind Value when studied in isolation, consideration of supply chain interactions pushes its Humankind Value higher.